A new generative artificial intelligence (AI) tool has been launched by H1, a global healthcare data company and will have a 'profound impact on clinical trial diversity'.
H1, the leading source of truth for global Healthcare Professional, clinical, scientific, and research information, today announced the launch of GenosAI, a new generative AI tool seamlessly embedded into its clinical trial intelligence platform, Trial Landscape, to analyze and respond to all types of complex inquiries.
Amsterdam, 3 Mei 2023 - Palo Alto Networks kondigt vandaag aan dat het zijn toonaangevende Machine Learning (ML)-Powered Next-Generation Firewall (NGFW) naar Microsoft Azure brengt als een volledig beheerde Azure-native ISV (Independent Software Vendor)-dienst (2023-05-03 11:12:39)